Ixekizumab superior to adalimumab for PsA
Crossref DOI link: https://doi.org/10.1038/s41584-019-0326-3
Published Online: 2019-10-15
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Collison, Joanna
Text and Data Mining valid from 2019-10-15
Version of Record valid from 2019-10-15
Article History
First Online: 15 October 2019
Free to read: This content has been made available to all.